Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marganit Shahar Gonen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ophthalmology Science|July 9, 2026
Machine Learning to Predict Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular DegenerationDavid M Wright, Ilanit Trifonov, Marganit Shahar-Gonen, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 22, 2022
Is There a Dose-Response Relationship? Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular DegenerationReut Shor, Adiel Barak, Anat Loewenstein, et al.
Retina (Philadelphia, Pa.)|January 6, 2026
Anti-VEGF Therapy Switching in Neovascular Age-Related Macular Degeneration: Insights from Automated Volumetric Retinal Fluid AnalysisOmer Dor, May Cohen, Marganit Shahar-Gonen, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 29, 2025
The British-Israeli Project for Algorithm-Based Management of Age-Related Macular Degeneration: Deep Learning Integration for Real-World Data Management and AnalysisDinah Zur, David M Wright, Marganit Shahar Gonen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ophthalmology Science|July 9, 2026
Machine Learning to Predict Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular DegenerationDavid M Wright, Ilanit Trifonov, Marganit Shahar-Gonen, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 22, 2022
Is There a Dose-Response Relationship? Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular DegenerationReut Shor, Adiel Barak, Anat Loewenstein, et al.
Retina (Philadelphia, Pa.)|January 6, 2026
Anti-VEGF Therapy Switching in Neovascular Age-Related Macular Degeneration: Insights from Automated Volumetric Retinal Fluid AnalysisOmer Dor, May Cohen, Marganit Shahar-Gonen, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 29, 2025
The British-Israeli Project for Algorithm-Based Management of Age-Related Macular Degeneration: Deep Learning Integration for Real-World Data Management and AnalysisDinah Zur, David M Wright, Marganit Shahar Gonen, et al.
Pageof 1